glp-1 receptor agonists and cancer risk in adults with obesity Semaglutide: What we know about safety GLP-1 Receptor Agonists and Cancer

Ready to Explore the Next Generation of Metabolic Treatment

Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome

It is important to note that, in the other large type 2 diabetes cardiovascular outcome trials, there were no statistically significant associations with the use of GLP-1/GIP agonists and negative eye outcomes

Glaucoma in adults-screening, diagnosis, and management: a review

doi: 10.2174/138161211798999456 34 HeuvelmanVDVan RaalteDHSmitsMM

As research continues to uncover its mechanisms and optimize its therapeutic application, allulose may emerge as a valuable tool in the management of metabolic disorders